General Information
Version
1.3
Revision date
2026-01-06
Product name
N2O 50 %;O2 50 %
Product name
N2O 50 %;O2 50 %
Identification on the label/Trade name
LIVOPAN 50%/50% medicinal gas, compressed
1.2.1 Relevant identified uses
Industrial and professional use for chemical analysis, calibration, (routine) quality control, laboratory use, under controlled conditions Perform risk assessment prior to use
1.2.2. Uses advised against
Consumer use Uses other than those listed above are not supported, contact your supplier for more information on other uses
Emergency telephone
+45 82 12 12 12
Icons in SDS
Company Information
company name
Linde Gas A/S
e-mail address of the competent person responsible for the Safety Data Sheet
sds.ren@linde.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H270, H280, H336
Hazard statements
Code
Statements
H270
May cause or intensify fire; oxidiser
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Physical hazards
Oxidising Gases, Category 1 H270 Gases under pressure Compressed gas H280
Health hazards
Specific target organ toxicity – Single exposure, Category 3, Narcosis H336 Full text of H- and EUH-statements: see section 16
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS03 GHS04 GHS07
Signal word
Danger
Contains
Nitrous Oxide
Hazard statements
H270 - May cause or intensify fire; oxidiser. H280 - Contains gas under pressure; may explode if heated. H336 - May cause drowsiness or dizziness.
Prevention
P220 - Keep away from combustible materials. P244 - Keep valves and fittings free from oil and grease. P260 - Do not breathe gas, vapours.
Response
P370+P376 - In case of fire: Stop leak if safe to do so. P304+P340+P315 - IF INHALED Remove person to fresh air and keep comfortable for breathing. Get immediate medical advice.
Storage
P403 - Store in a well-ventilated place.
Other hazards
Not classified as PBT or vPvB. The substance/mixture has no endocrine disrupting properties. The substance/mixture has no endocrine disrupting properties. Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Physical hazards Oxidising Gases, Category 1 H270 Gases under pressure : Compressed gas H280 Health hazards Specific target organ toxicity – Single exposure, Category 3, Narcosis H336 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available
